secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVELATION BIOSCIENCES, INC. (REVB)
CIK:        0001810560
Form:       8-K
Filed at:   2022-12-21T23:59:59+00:00
Accession:  0000950170-22-026866
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 5.03, 3.02, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Revelation Biosciences issues CEO one share of Series A Preferred with 50M votes to secure reverse stock split approval
--------------------------------------------------------------------------------

- CEO James Rolke purchased one share of Series A Preferred for $5,000 cash.
- Preferred carries 50,000,000 votes, only on proposals to increase authorized common stock and effect reverse stock split.
- Preferred votes in proportion to common stock votes on those proposals; no other voting rights.
- Non-convertible, no dividends, no liquidation rights; redeemable at $5,000 upon board order or automatically upon reverse split effectiveness.
- Transfer restricted without board consent; issuance exempt under Section 4(a)(2).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1810560/000095017022026866/0000950170-22-026866-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1810560/000095017022026866/revb-20221219.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-026866

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer